CI Investments Inc’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-733
Closed -$180K 1422
2022
Q3
$180K Sell
733
-25
-3% -$6.75K ﹤0.01% 618
2022
Q2
$188K Sell
758
-170
-18% -$45.9K ﹤0.01% 613
2022
Q1
$307K Sell
928
-92
-9% -$28.3K ﹤0.01% 625
2021
Q4
$366K Buy
1,020
+37
+4% +$12.5K ﹤0.01% 654
2021
Q3
$320K Buy
983
+258
+36% +$87.4K ﹤0.01% 667
2021
Q2
$226K Sell
725
-299
-29% -$91.7K ﹤0.01% 721
2021
Q1
$326K Buy
1,024
+298
+41% +$95.4K ﹤0.01% 605
2020
Q4
$235K Buy
726
+264
+57% +$73K ﹤0.01% 644
2020
Q3
$128K Buy
462
+113
+32% +$32.6K ﹤0.01% 624
2020
Q2
$84K Buy
+349
New +$70.1K ﹤0.01% 601
2019
Q1
Sell
-34
Closed -$11K 376
2018
Q4
$11K Buy
+34
New +$11.8K ﹤0.01% 331

Other funds holding ABMD

CI Investments Inc's ABMD Position: Q4 2022 in Review

CI Investments Inc sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 733 shares — an estimated $180K sold.

CI Investments Inc first reported a position in ABMD in Q4 2018 and held it in 11 quarters. The position peaked at $366K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • CI Investments Inc reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • CI Investments Inc sold 733 Abiomed Inc shares in Q4 2022, an estimated $180K.
  • CI Investments Inc first reported a position in Abiomed Inc in Q4 2018 and held it in 11 quarters.
  • CI Investments Inc's Abiomed Inc position peaked at $366K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on CI Investments Inc's 13F filing for Q4 2022, filed 10 Feb 2023.